<DOC>
	<DOCNO>NCT02844790</DOCNO>
	<brief_summary>This trial conduct Asia . The aim trial investigate pharmacokinetic ( exposure trial drug body ) property insulin degludec/insulin aspart healthy Chinese subject .</brief_summary>
	<brief_title>A Trial Investigating Pharmacokinetic Properties Insulin Degludec/Insulin Aspart Healthy Chinese Subjects</brief_title>
	<detailed_description />
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin degludec , insulin aspart drug combination</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin , Long-Acting</mesh_term>
	<mesh_term>Insulin Aspart</mesh_term>
	<criteria>Male female Chinese subject age 1845 year ( inclusive ) Considered generally healthy upon completion medical history , physical examination , vital sign electrocardiogram ( ECG ) , judge investigator Body mass index 19.024.0 kg/m^2 ( inclusive ) A history illness , opinion investigator , might confound result trial pose risk administer trial product subject Subject donate blood plasma past month 400 mL within 3 month prior screen Smoking 5 cigarette ( include nicotine substitute product ) , equivalent , per</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>